| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.45 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |